These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7878250)

  • 1. [Magnetic resonance diagnosis of Hallervorden-Spatz disease].
    Bonetti M; Prandini F; Gasparotti R; Pavia M; Crispino M; Pittiani F
    Radiol Med; 1994 Dec; 88(6):869-70. PubMed ID: 7878250
    [No Abstract]   [Full Text] [Related]  

  • 2. Hallervorden-Spatz syndrome resembling a typical Tourette syndrome.
    Scarano V; Pellecchia MT; Filla A; Barone P
    Mov Disord; 2002 May; 17(3):618-20. PubMed ID: 12112223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of Hallervorden-Spatz syndrome--clinical course and successive findings of brain CT].
    Yamada T
    No To Hattatsu; 1991 Nov; 23(6):628-30. PubMed ID: 1760214
    [No Abstract]   [Full Text] [Related]  

  • 4. Hallervorden Spatz disease.
    Singhi PD
    Indian Pediatr; 1996 Mar; 33(3):252-3. PubMed ID: 8772856
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hallervorden-Spatz syndrome. Indicative findings in cranial computerized and magnetic resonance tomography for intra vitam diagnosis].
    Kurlemann G; Bongartz G; Kuchelmeister K; Palm DG
    Monatsschr Kinderheilkd; 1991 Sep; 139(9):626-8. PubMed ID: 1745254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of Hallervorden-Spatz syndrome diagnosed antemortemly.
    Thajeb P
    Chin Med J (Engl); 1993 Feb; 106(2):153-6. PubMed ID: 8504699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations.
    Sethi KD; Adams RJ; Loring DW; el Gammal T
    Ann Neurol; 1988 Nov; 24(5):692-4. PubMed ID: 3202617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Importance of magnetic resonance in the diagnosis of Hallervorden- Spatz disease: presentation of a case with familial history].
    Pérez Sempere A; Martínez Menéndez B; Villaverde Amundarain FJ; Calandre Hoenigsfeld L; Bermejo Pareja F
    Neurologia; 1990; 5(7):252-3. PubMed ID: 2288756
    [No Abstract]   [Full Text] [Related]  

  • 9. 123I-ioflupane SPECT findings of pantothenate kinase-associated neurodegeneration.
    Kang A; Minoshima S
    Clin Nucl Med; 2014 Sep; 39(9):849-51. PubMed ID: 24999676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography in Hallervorden-Spatz disease.
    Dooling EC; Richardson EP; Davis KR
    Neurology; 1980 Oct; 30(10):1128-30. PubMed ID: 7191506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiologic features of Hallervorden Spatz Disease.
    Asumal KB; Wasay M; Ali SN
    J Pak Med Assoc; 2002 Nov; 52(11):528-30. PubMed ID: 12585374
    [No Abstract]   [Full Text] [Related]  

  • 12. Hallervorden Spatz disease.
    Sabat SB; Deshmukh MP
    J Assoc Physicians India; 2006 Aug; 54():629. PubMed ID: 16941794
    [No Abstract]   [Full Text] [Related]  

  • 13. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
    Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T
    Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic resonance tomography confirms the diagnosis of Hallervorden-Spatz disease].
    Scheer PJ; Perz A; Ebner F; Kratky-Dunitz M
    Padiatr Padol; 1988; 23(3):245-52. PubMed ID: 3186269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallervorden-Spatz disease.
    Boyacigil S; Tokoğlu F; Paşaoğlu E; Ardiç S; Comoğlu S; Saka M; Oztürk S
    Australas Radiol; 1996 Aug; 40(3):351-3. PubMed ID: 8826751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nuclear magnetic resonance tomography and differential diagnosis of Hallervorden-Spatz disease].
    Schneider S; Ott D; Sauer M
    Nervenarzt; 1992 Feb; 63(2):105-7. PubMed ID: 1565166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed tomography in Hallervorden-Spatz disease.
    Boltshauser E; Lang W; Janzer R; Briner J; Spiess H; Kleihues P; Isler W
    Neuropediatrics; 1987 May; 18(2):81-3. PubMed ID: 3601001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron deposits in the subthalamic nuclei in Hallervorden-Spatz disease.
    Müller T; Amoiridis G; Kuhn W; Przuntek H
    Eur Neurol; 1999; 42(4):240-1. PubMed ID: 10567823
    [No Abstract]   [Full Text] [Related]  

  • 19. Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome.
    Hayflick SJ; Penzien JM; Michl W; Sharif UM; Rosman NP; Wheeler PG
    Pediatr Neurol; 2001 Aug; 25(2):166-9. PubMed ID: 11551748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pantothenate kinase associated neurodegeneration (Hallervorden-Spatz syndrome).
    Kapoor S; Hortnagel K; Gogia S; Paul R; Malhotra V; Prakash A
    Indian J Pediatr; 2005 Mar; 72(3):261-3. PubMed ID: 15812126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.